Identification of the HIV-1 gp41 core-binding motif in the scaffolding domain of caveolin-1

被引:40
作者
Huang, Jing-He
Lu, Lu
Lu, Hong
Chen, Xi
Jiang, Shibo [1 ]
Chen, Ying-Hua
机构
[1] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10021 USA
[2] Tsinghua Univ, Immunol Lab, Dept Biol, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China
关键词
D O I
10.1074/jbc.M607701200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The human immunodeficiency virus, type I (HIV-1) gp41 core plays an important role in fusion between viral and target cell membranes. A single chain polypeptide, N36(L8)C34, which forms a six-helix bundle in physiological solution, can be used as a model of gp41 core. Here we identified from a 12-mer phage peptide library a positive phage clone displaying a peptide sequence with high binding activity to the HIV-I gp41 core. The peptide sequence contains a putative gp41-binding motif, Phi XXXX Phi X Phi (X is any amino acid residue, and Phi is any one of the aromatic amino acid residues Trp, Phe, or Tyr). This motif also exists in the scaffolding domain of caveolin-1 (Cav-1), a known gp41-binding protein. Cav-1-(61-101) and Cav-l-(82-101), two recombinant fusion proteins containing the Cav-1 scaffolding domain, bound significantly to the gp41 expressed in mammalian cells and interacted with the polypeptide N36(L8)C34. These results suggest that the scaffolding domain of Cav-1 may bind to the gp41 core via the motif. This interaction may be essential for formation of fusion pore or endocytosis of HIV-I and affect the pathogenesis of HIV-1 infection. Further characterization of the gp41 core-binding motifs may shed light on the alternative mechanism by which HIV-1 enters into the target cell.
引用
收藏
页码:6143 / 6152
页数:10
相关论文
共 34 条
[1]
Becker KA, 1999, J CELL SCI, V112, P97
[2]
Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[3]
Lipid rafts and HIV-1: from viral entry to assembly of progeny virions [J].
Campbell, SM ;
Crowe, SM ;
Mak, J .
JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (03) :217-227
[4]
Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[5]
HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[6]
QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[7]
Identification of peptide and protein ligands for the caveolin-scaffolding domain - Implications for the interaction of caveolin with caveolae-associated proteins [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Ikezu, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6525-6533
[8]
Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: Implications for fusion-inducing conformational changes [J].
de Rosny, E ;
Vassell, R ;
Jiang, S ;
Kunert, R ;
Weiss, CD .
JOURNAL OF VIROLOGY, 2004, 78 (05) :2627-2631
[9]
Alterations of lymphocyte membranes during HIV-1 infection via multiple and simultaneous entry strategies [J].
Fermin, C ;
Garry, R .
MICROSCOPY RESEARCH AND TECHNIQUE, 2005, 68 (3-4) :149-167
[10]
Galli T, 2001, Sci STKE, V2001, pre1